TelyRx Holdings Inc. shares surged by over 22% in the latest trading session, reflecting strong investor interest.
In a remarkable one-day performance, TelyRx Holdings Inc. (TELY.TO) saw its stock price jump by 22.45%, closing at CA$3.00. This surge comes amid increasing investor enthusiasm following the company's recent developments.
Investor takeaway: Investors should consider the implications of TelyRx's stock surge and monitor any forthcoming announcements that could impact its trajectory.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$73.09M
52W high
$4.25
52W low
$2.00
1W change
-4.51%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 118.2% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+118.2% Upside
Current Price
C$2.75
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
107.5%
Annualized
90-Day Vol
102.2%
Annualized
Trend (90d)
-36.5%
Annualized drift
90d Mean
C$2.41
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.63 | C$1.82 – C$3.82 |
| 60 trading days | C$2.52 | C$1.49 – C$4.26 |
| 90 trading days | C$2.41 | C$1.27 – C$4.59 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
TelyRx Holdings Inc. Stock Up 22.45%
Advertisement
With a market cap of CA$65.12 million, TelyRx's significant one-day gain highlights its potential volatility and investor interest.
Bull case
The recent spike in TelyRx's stock price suggests that investors are growing more confident in the company's future. This optimism follows TelyRx's transition to the Toronto Stock Exchange and its recent financial disclosures, which may have reassured investors about its prospects.
Bear case
Despite the positive movement, TelyRx's ongoing losses and lack of dividends could raise concerns about its long-term sustainability and profitability. Investors should weigh these risks carefully before making decisions.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
